Skip to main content
. 2021 May 25;22(11):5569. doi: 10.3390/ijms22115569

Figure 1.

Figure 1

Effects of AdipoRon treatment on cell viability and cell cycle distribution in Osteosarcoma cells. U2OS (a), Saos-2 (b) and MG-63 (c) were supplemented with AdipoRon (from 1.25 μg/mL to 40 μg/mL) for 72 h in order to assess both cell viability and IC50 by MTT assay. U2OS (d), Saos-2 (e) and MG-63 (f) were grown in presence and absence of 20 μg/mL AdipoRon for 48 h and then compared for cell phase distribution by FACS analysis. Data reported in the figure above have already been published [61].